World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
87
Citations
30095
World Ranking
796
National Ranking
13

Nicola Normanno publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Nicola Normanno sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 442 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Nicola Normanno D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Nicola Normanno sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 87 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Nicola Normanno is affiliated with the Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" in Italy and has an extensive research portfolio primarily focused on medicine and biochemistry, genetics, and molecular biology. Their work covers key subfields such as oncology, pulmonary and respiratory medicine, cancer research, molecular biology, and pathology and forensic medicine.

Their research addresses several critical topics including cancer genomics and diagnostics, lung cancer treatments and mutations, colorectal cancer treatments and studies, genetic factors in colorectal cancer, cancer immunotherapy and biomarkers, radiomics and machine learning in medical imaging, and gastric cancer management and outcomes.

Nicola Normanno has published numerous papers in respected journals, including these recent notable works:

  • Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2022), Annals of Oncology
  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group (2020), Annals of Oncology
  • ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group (2022), Annals of Oncology
  • Delivering precision oncology to patients with cancer (2022), Nature Medicine
  • Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group (2024), Annals of Oncology

The scholar has collaborated frequently with several co-authors, including Carmine Pinto, Evaristo Maiello, Alessandro Morabito, Antonio Avallone, and Riziero Esposito Abate, reflecting a network of researchers engaged in oncology and precision medicine.

Normanno's publications span multiple prestigious venues, with significant contributions to:

  • Annals of Oncology
  • Cancers
  • Journal of Clinical Oncology
  • ESMO Open
  • Zenodo (CERN European Organization for Nuclear Research)

The researcher's body of work includes 378 publications in medicine and 163 in biochemistry, genetics, and molecular biology, evidencing deep interdisciplinary engagement. Their oncology-related publications count 147, while contributions in pulmonary and respiratory medicine reach 102. Additional substantial work has been published in cancer research and molecular biology, with 90 and 52 publications respectively.

The focus on cancer genomics and diagnostics is reflected in 168 publications, with related significant areas including lung and colorectal cancer studies. Normanno's research covers emerging areas such as cancer immunotherapy and the application of radiomics and machine learning in medical imaging, indicating active involvement in precision oncology trends.

Best Publications

  • Epidermal growth factor-related peptides and their receptors in human malignancies

    David S. Salomon;Ralf Brandt;Fortunato Ciardiello;Nicola Normanno

  • Epidermal growth factor receptor (EGFR) signaling in cancer

    Nicola Normanno;Antonella De Luca;Caterina Bianco;Luigi Strizzi

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.

    F. Mosele;J. Remon;J. Mateo;C. B. Westphalen

  • The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

    Unknown

  • Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.

    N Normanno;C Bianco;A De Luca;M R Maiello

  • The role of the EGFR signaling in tumor microenvironment

    Unknown

  • The ErbB receptors and their ligands in cancer: an overview.

    N. Normanno;C. Bianco;L. Strizzi;M. Mancino

  • Implementing TMB measurement in clinical practice: considerations on assay requirements

    Reinhard Büttner;John W Longshore;Fernando López-Ríos;Sabine Merkelbach-Bruse

  • The role of EGF-related peptides in tumor growth.

    Normanno N;Bianco C;De Luca A;Salomon Ds

  • Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis

    Luigi Strizzi;Caterina Bianco;Nicola Normanno;David Salomon

  • Guidance for laboratories performing molecular pathology for cancer patients.

    Ian A Cree;Ian A Cree;Zandra Deans;Marjolijn J L Ligtenberg;Nicola Normanno

  • Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo

    Heather B. Adkins;Caterina Bianco;Susan G. Schiffer;Paul Rayhorn

  • Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line.

    Giuseppe Pirozzi;Virginia Tirino;Rosa Camerlingo;Renato Franco

  • The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

    Nicola Normanno;Antonella De Luca;Monica R. Maiello;Manuela Campiglio

  • EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.

    Yasushi Yatabe;Keith M Kerr;Ahmad Rusdan Handoyo Utomo;Pathmanathan A Rajadurai

  • Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.

    Toshiaki Saeki;Kurt Stromberg;Chen Feng Qi;William J. Gullick

  • Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells

    Caterina Bianco;Heather B. Adkins;Heather B. Adkins;Christian Wechselberger;Masaharu Seno

  • The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.

    D S Saloman;C Bianco;A D Ebert;N I Khan

  • Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.

    Luigi Strizzi;Caterina Bianco;Nicola Normanno;Masaharu Seno

  • Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

    Unknown

Frequent Co-Authors

Fortunato Ciardiello
Fortunato Ciardiello University of Campania "Luigi Vanvitelli"
David S. Salomon
David S. Salomon National Institutes of Health
Gerardo Botti
Gerardo Botti Istituto Giannina Gaslini
Renato Franco
Renato Franco University of Campania "Luigi Vanvitelli"
Aldo Scarpa
Aldo Scarpa University of Verona
Antonio Russo
Antonio Russo University of Palermo
Giuseppe Tonini
Giuseppe Tonini Università Campus Bio-Medico
Martin Reck
Martin Reck LungenClinic Grosshansdorf
Michele Caraglia
Michele Caraglia University of Campania "Luigi Vanvitelli"
Stefano Pepe
Stefano Pepe University of Salerno

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a degree in Molecular Biology, you may also be interested in other online options that support diverse career pathways in science, education, and healthcare. Many students find value in expanding their expertise or switching fields with affordable, flexible online programs.

For those drawn to research or education, history and library science offer strong complementary skill sets. You can find some of the cheapest online masters in history and the cheapest library science degree online for innovative skill-building and career transition opportunities.

Healthcare and clinical communication are also attractive routes. Individuals interested in Speech-Language Pathology may consider asha accredited online slp master's programs or, for those without a relevant undergraduate major, bridge programs such as slp bridge program options.

Exploring these related online degrees opens doors to interdisciplinary careers while providing flexibility and affordability—ideal for students seeking alternative pathways in the dynamic sciences.

Best Scientists Citing Nicola Normanno

Trending Scientists